<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): April 1, 2009 (March 27, 2009)</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>Lifevantage Corporation<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Colorado</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>000-30489</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>90-0224471</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>11545 W. Bernardo Court, Suite 301, San Diego, California <BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>92127</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(858) 312-8000</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>Item&nbsp;5.02</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers</B></DIV></TD>
</TR>

</TABLE>


<P align="justify" style="font-size: 10pt"><U>Amendment to 2007 Long Term Incentive Plan</U>


<P align="justify" style="font-size: 10pt">On March&nbsp;27, 2009, the Board of Directors of Lifevantage Corporation (the &#147;Company&#148;) approved an amendment to the
Company&#146;s 2007 Long Term Incentive Plan (the &#147;Plan&#148;) in order to increase the number of shares reserved for issuance
under the Plan to 10,000,000 shares of common stock. The Company will submit the amendment to the Plan to the
shareholders of the Company for approval at the next annual meeting of shareholders.


<P align="justify" style="font-size: 10pt"><U>Option Grants</U>


<P align="justify" style="font-size: 10pt">On March&nbsp;27, 2009, the Board of Directors of the Company approved option grants to the Company&#146;s Chief Executive
Officer and Chief Financial Officer. David Brown, the Company&#146;s Chief Executive Officer, received an incentive stock
option grant to purchase 300,000 shares of common stock of the Company. Brad Amman, the Company&#146;s Chief Financial
Officer, received an incentive stock option grant to purchase 120,000 shares of common stock of the Company (the
&#147;Options&#148;). Each of the Options has an exercise price of $0.70, which was the closing price of the Company&#146;s common
stock as quoted on the OTC Bulletin Board on the date of grant. The Options will vest in full on the date that is
twelve months following the date of grant and are subject to the terms of the Plan.

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="justify" style="font-size: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.


<P align="justify" style="font-size: 10pt">Date: April&nbsp;1, 2009


<P align="justify" style="font-size: 10pt; margin-left: 48%">LIFEVANTAGE CORPORATION

<P>
<P align="justify" style="font-size: 10pt; margin-left: 48%">By: <U><I>/s/ Bradford K. Amman</I></U><BR>
Bradford K. Amman<BR>
Chief Financial Officer<BR>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c83452e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 7297}]
{"company-data": {"conformed-name": "Lifevantage Corp", "cik": "0000849146", "assigned-sic": "2834", "irs-number": "841097796", "state-of-incorporation": "CO", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-30489", "film-number": "09724902"}, "business-address": {"street1": "6400 SOUTH FIDDLER", "street2": "SUITE 1750", "city": "ENGLEWOOD", "state": "CO", "zip": "80111", "phone": "720-488-1711"}, "mail-address": {"street1": "6400 SOUTH FIDDLER", "street2": "SUITE 1750", "city": "ENGLEWOOD", "state": "CO", "zip": "80111"}, "former-company": [{"former-conformed-name": "LIFELINE THERAPEUTICS, INC.", "date-changed": "20041019"}, {"former-conformed-name": "YAAK RIVER RESOURCES INC", "date-changed": "19920703"}, {"former-conformed-name": "ANDRAPLEX CORP", "date-changed": "19920406"}]}
Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2009 (March 27, 2009)
Lifevantage Corporation
(Exact name of registrant as specified in its charter)
Colorado
000-30489
90-0224471
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
11545 W. Bernardo Court, Suite 301, San Diego, California
92127
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(858) 312-8000
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
Amendment to 2007 Long Term Incentive Plan
On March 27, 2009, the Board of Directors of Lifevantage Corporation (the "Company") approved an amendment to the
Company's 2007 Long Term Incentive Plan (the "Plan") in order to increase the number of shares reserved for issuance
under the Plan to 10,000,000 shares of common stock. The Company will submit the amendment to the Plan to the
shareholders of the Company for approval at the next annual meeting of shareholders.
Option Grants
On March 27, 2009, the Board of Directors of the Company approved option grants to the Company's Chief Executive
Officer and Chief Financial Officer. David Brown, the Company's Chief Executive Officer, received an incentive stock
option grant to purchase 300,000 shares of common stock of the Company. Brad Amman, the Company's Chief Financial
Officer, received an incentive stock option grant to purchase 120,000 shares of common stock of the Company (the
"Options"). Each of the Options has an exercise price of $0.70, which was the closing price of the Company's common
stock as quoted on the OTC Bulletin Board on the date of grant. The Options will vest in full on the date that is
twelve months following the date of grant and are subject to the terms of the Plan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.
Date: April 1, 2009
LIFEVANTAGE CORPORATION
By:
/s/ Bradford K. Amman
Bradford K. Amman
Chief Financial Officer